Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $4.53 Million - $5.1 Million
-15,500 Reduced 14.61%
90,600 $29.8 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $707,746 - $864,318
2,600 Added 2.51%
106,100 $32.3 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $5.27 Million - $6.36 Million
-23,400 Reduced 18.44%
103,500 $28 Million
Q1 2021

May 14, 2021

SELL
$212.38 - $245.9 $13.1 Million - $15.2 Million
-61,900 Reduced 32.79%
126,900 $28.6 Million
Q4 2020

Feb 12, 2021

BUY
$212.5 - $245.46 $32.6 Million - $37.7 Million
153,400 Added 433.33%
188,800 $41.9 Million
Q3 2020

Nov 13, 2020

BUY
$177.16 - $215.33 $3.61 Million - $4.39 Million
20,400 Added 136.0%
35,400 $7.62 Million
Q1 2019

May 14, 2019

SELL
$97.62 - $132.29 $9.76 Million - $13.2 Million
-100,000 Reduced 86.96%
15,000 $1.98 Million
Q1 2018

May 15, 2018

BUY
$92.16 - $103.8 $10.6 Million - $11.9 Million
115,000 New
115,000 $11.3 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.